Biotricity Inc

Good day and welcome to Biotricity's Fiscal 2022 Third Quarter Financial Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Deborah Chen.

Please go ahead.

Good afternoon, everyone, and welcome to Biotricity's Fiscal 2022 Third Quarter Earnings Conference Call. As a reminder, Biotricity's third fiscal 2022 quarter ended on December 31, 2021, so all figures presented for this period will reflect that end date. Yesterday, we issued our fiscal 2022 third quarter results press release, which highlighted a number of financial results. A copy of this press release is available on the investor relations section of our website, and the full financials will be filed with the SEC on Form 10-K and posted on Egger. Before beginning our formal remarks, I'd like to remind listeners that today's discussion may contain forward-looking statements that reflect management's current views with respect to future events. Any such statements are subject to risk and uncertainties that could cause actual results to differ materially from those projected in these forward-looking statements. Biotricity does not undertake to update any forward-looking statements except as required. At this point, I'm pleased to turn the call over to Biotricity's founder and CEO, Dr. Waqas Al-Siddiq. Please go ahead.